Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, September 12, 2022
WuXi STA, a subsidiary of WuXi AppTec, announced the opening of a new sterile lipid nanoparticle (LNP) formulation development and manufacturing facility at its Wuxi city campus. Created in response to the increasing demand for complex injection ...
read more
Hovione has announced the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
read more
Wednesday, February 27, 2019
Notable has expanded its management team with Hiroomi Tada as Chief Medical Officer and Lloyd Mackenzie as Chief Development Officer.
read more
Monday, February 01, 2016
Bristol-Myers Squibb Company and Pfizer have announced that the companies have entered into a collaboration agreement with Portola Pharmaceuticals Inc. to develop and commercialize the investigational agent andexanet alfa in Japan. Andexanet alfa, ...
read more
Intec has entered into an agreement with Novartis to explore using the Accordion Pill platform for a proprietary compound.
read more
Wednesday, February 14, 2018
Seattle Genetics has received exclusive worldwide rights to certain PharmaMar proprietary molecules for the development, manufacture and commercialization of ADCs.
read more
WuXi STA, a subsidiary of WuXi AppTec, has opened a new continuous manufacturing (flow chemistry) plant at its Changzhou campus in China for large-scale active pharmaceutical ingredient (API) and advanced intermediate production.
read more
Wednesday, August 31, 2022
Ashland announced a strategically significant expansion of its Viatel™ bioresorbable polymer manufacturing and research and development site at the National Science Park, home to a network of innovative organizations, in Mullingar, Ireland.
read more
Thursday, October 31, 2019
Pharma Logistics acquired the pharmaceutical reverse distribution division of Stericycle, effective October 28, 2019.
read more
Monday, December 28, 2015
Galapagos NV and Gilead Sciences, Inc. have entered into a global partnership for the development and commercialization of the JAK1-selective inhibitor filgotinib for inflammatory disease indications.
read more
Thursday, February 22, 2018
Envigo announced the appointment of Lynn Lewis to the position of Senior Vice President, Global Sales.
read more
Wednesday, August 12, 2020
The FDA approved the first liquid biopsy companion diagnostic that also uses NGS technology to identify patients with specific types of mutations of the EGFR gene.
read more
Cambrex announced that Snapdragon Chemistry, a Cambrex company, has expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts to further support the development and manufacturing of peptide therapies.
read more
Samsung Biologics, a contract development and manufacturing organization (CMDO), celebrated the one-year mark of Live Virtual Tour (LVT), a platform to provide remote site inspections for clients and regulatory agencies. The tool was developed and ...
read more
BioAgilytix Labs, LLC, a global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all stages of large molecule drug development, announced that it signed a definitive agreement to purchase 360biolabs®, the ...
read more